BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 23178257)

  • 1. Vitamin D receptor signaling mechanisms: integrated actions of a well-defined transcription factor.
    Carlberg C; Campbell MJ
    Steroids; 2013 Feb; 78(2):127-36. PubMed ID: 23178257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current status of vitamin D signaling and its therapeutic applications.
    Carlberg C; Molnar F
    Curr Top Med Chem; 2012; 12(6):528-47. PubMed ID: 22242854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The first genome-wide view of vitamin D receptor locations and their mechanistic implications.
    Carlberg C; Seuter S; Heikkinen S
    Anticancer Res; 2012 Jan; 32(1):271-82. PubMed ID: 22213316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic mechanisms involved in the pleiotropic actions of 1,25-dihydroxyvitamin D3.
    Christakos S; Raval-Pandya M; Wernyj RP; Yang W
    Biochem J; 1996 Jun; 316 ( Pt 2)(Pt 2):361-71. PubMed ID: 8687373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamics of 1α,25-dihydroxyvitamin D3-dependent chromatin accessibility of early vitamin D receptor target genes.
    Seuter S; Pehkonen P; Heikkinen S; Carlberg C
    Biochim Biophys Acta; 2013 Dec; 1829(12):1266-75. PubMed ID: 24185200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin D receptor(s): In the nucleus but also at membranes?
    Zmijewski MA; Carlberg C
    Exp Dermatol; 2020 Sep; 29(9):876-884. PubMed ID: 32654294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin D receptor (VDR)-mediated actions of 1α,25(OH)₂vitamin D₃: genomic and non-genomic mechanisms.
    Haussler MR; Jurutka PW; Mizwicki M; Norman AW
    Best Pract Res Clin Endocrinol Metab; 2011 Aug; 25(4):543-59. PubMed ID: 21872797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carboxylic ester antagonists of 1alpha,25-dihydroxyvitamin D(3) show cell-specific actions.
    Herdick M; Steinmeyer A; Carlberg C
    Chem Biol; 2000 Nov; 7(11):885-94. PubMed ID: 11094341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on biological actions of 1alpha,25(OH)2-vitamin D3 (rapid effects) and 24R,25(OH)2-vitamin D3.
    Norman AW; Okamura WH; Bishop JE; Henry HL
    Mol Cell Endocrinol; 2002 Nov; 197(1-2):1-13. PubMed ID: 12431790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The vitamin D hormone and its nuclear receptor: molecular actions and disease states.
    Haussler MR; Haussler CA; Jurutka PW; Thompson PD; Hsieh JC; Remus LS; Selznick SH; Whitfield GK
    J Endocrinol; 1997 Sep; 154 Suppl():S57-73. PubMed ID: 9379138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin D receptor signaling and its therapeutic implications: Genome-wide and structural view.
    Carlberg C; Molnár F
    Can J Physiol Pharmacol; 2015 May; 93(5):311-8. PubMed ID: 25741777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nongenotropic, anti-apoptotic signaling of 1alpha,25(OH)2-vitamin D3 and analogs through the ligand binding domain of the vitamin D receptor in osteoblasts and osteocytes. Mediation by Src, phosphatidylinositol 3-, and JNK kinases.
    Vertino AM; Bula CM; Chen JR; Almeida M; Han L; Bellido T; Kousteni S; Norman AW; Manolagas SC
    J Biol Chem; 2005 Apr; 280(14):14130-7. PubMed ID: 15671029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Membrane actions of vitamin D metabolites 1alpha,25(OH)2D3 and 24R,25(OH)2D3 are retained in growth plate cartilage cells from vitamin D receptor knockout mice.
    Boyan BD; Sylvia VL; McKinney N; Schwartz Z
    J Cell Biochem; 2003 Dec; 90(6):1207-23. PubMed ID: 14635194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The anti-cancer actions of vitamin D.
    Chiang KC; Chen TC
    Anticancer Agents Med Chem; 2013 Jan; 13(1):126-39. PubMed ID: 23094926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin D and Its Target Genes.
    Carlberg C
    Nutrients; 2022 Mar; 14(7):. PubMed ID: 35405966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-wide effects of chromatin on vitamin D signaling.
    Hanel A; Malmberg HR; Carlberg C
    J Mol Endocrinol; 2020 May; 64(4):R45-R56. PubMed ID: 32229699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenomic PU.1-VDR crosstalk modulates vitamin D signaling.
    Seuter S; Neme A; Carlberg C
    Biochim Biophys Acta Gene Regul Mech; 2017 Apr; 1860(4):405-415. PubMed ID: 28232093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear hormone 1α,25-dihydroxyvitamin D3 elicits a genome-wide shift in the locations of VDR chromatin occupancy.
    Heikkinen S; Väisänen S; Pehkonen P; Seuter S; Benes V; Carlberg C
    Nucleic Acids Res; 2011 Nov; 39(21):9181-93. PubMed ID: 21846776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minireview: vitamin D receptor: new assignments for an already busy receptor.
    Norman AW
    Endocrinology; 2006 Dec; 147(12):5542-8. PubMed ID: 16946007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New understanding of the molecular mechanism of receptor-mediated genomic actions of the vitamin D hormone.
    Haussler MR; Jurutka PW; Hsieh JC; Thompson PD; Selznick SH; Haussler CA; Whitfield GK
    Bone; 1995 Aug; 17(2 Suppl):33S-38S. PubMed ID: 8579895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.